Nyxoah (NYXH) P/E (2021 - 2026)
Nyxoah (NYXH) P/E from Apr 28, 2021 to Jul 20, 2026. The TTM Nyxoah (NYXH) P/E is -0.61. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Nyxoah (NYXH)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.61 | -64.05% |
| 2025 | -1.69 | -59.12% |
| 2024 | -4.13 | +61.51% |
| 2023 | -2.56 | -48.59% |
| 2022 | -4.98 | -70.76% |
| 2021 | -17.02 | N/A |
Comparison Nyxoah (NYXH) P/E with competitors
Nyxoah (NYXH) P/E is -0.61.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -136.87% |
| EMBC | Embecta Corp | 1.69 | -378.31% |
| SOLV | Solventum Corp | 9.49 | -1662.97% |
| ZJYL | Jin Medical International Ltd | 12.75 | -2198.92% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -2606.05% |
| RMD | Resmed Inc | 19.04 | -3236.00% |
| UTMD | Utah Medical Products Inc | 20.76 | -3518.35% |
| ATR | Aptargroup Inc | 21.65 | -3664.49% |
| ALGN | Align Technology Inc | 30.29 | -5087.91% |
| HOLX | Hologic Inc | 30.86 | -5182.17% |
| MMSI | Merit Medical Systems Inc | 31.15 | -5228.62% |
| STVN | Stevanato Group Spa | 31.25 | -5246.40% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -6083.93% |
| ALC | Alcon Inc | 41.51 | -6935.97% |
| ISRG | Intuitive Surgical Inc | 46.43 | -7744.86% |
| BDX | Becton Dickinson & Company | 46.93 | -7827.95% |
| WST | West Pharmaceutical Services Inc | 47.41 | -7906.28% |
| NEPH | Nephros Inc | 50.00 | -8332.56% |
| COO | Cooper Companies Inc | 58.98 | -9811.57% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | -10341.92% |
| NVST | Envista Holdings Corp | 64.66 | -10747.75% |
| BAX | Baxter International Inc | 72.66 | -12063.81% |
| ICUI | ICU Medical Inc | 84.82 | -14066.80% |
| RGEN | Repligen Corp | 162.20 | -26807.84% |
| WRBY | Warby Parker Inc - Class A | 318.30 | -52512.08% |